Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00979745
Recruitment Status : Completed
First Posted : September 18, 2009
Last Update Posted : August 4, 2011
Information provided by:
Clinuvel Pharmaceuticals Limited